MY186726A - Anti-activin a antibodies and uses thereof - Google Patents
Anti-activin a antibodies and uses thereofInfo
- Publication number
- MY186726A MY186726A MYPI2016700339A MYPI2016700339A MY186726A MY 186726 A MY186726 A MY 186726A MY PI2016700339 A MYPI2016700339 A MY PI2016700339A MY PI2016700339 A MYPI2016700339 A MY PI2016700339A MY 186726 A MY186726 A MY 186726A
- Authority
- MY
- Malaysia
- Prior art keywords
- antibodies
- activin
- useful
- treatment
- diseases
- Prior art date
Links
Abstract
The present invention provides antibodies that bind to Activin A and methods of using the same. According to certain embodiments of the invention, the antibodies are fully human antibodies that bind to Activin A with high affinity. The antibodies of the invention are useful for the treatment of diseases and disorders characterized by decreased muscle mass or strength, such as sarcopenia, cachexia, muscle injury, muscle wasting/at rophy, cancer, fibrosis, and weight loss. The antibodies of the invention are also useful in combination with GDF8 binding proteins for the treatment of diseases and disorders characterized by decreased muscle mass or strength. The antibodies of the invention are also useful for the prevention, treatment, or amelioration of disorders and diseases caused by, promoted by, exacerbated by, and/or aggravated by Activin A, such as renal fibrosis.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361859926P | 2013-07-30 | 2013-07-30 | |
US201361864036P | 2013-08-09 | 2013-08-09 | |
US201361911834P | 2013-12-04 | 2013-12-04 | |
PCT/US2014/048957 WO2015017576A1 (en) | 2013-07-30 | 2014-07-30 | Anti-activin a antibodies and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
MY186726A true MY186726A (en) | 2021-08-13 |
Family
ID=81329898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MYPI2016700339A MY186726A (en) | 2013-07-30 | 2014-07-30 | Anti-activin a antibodies and uses thereof |
Country Status (1)
Country | Link |
---|---|
MY (1) | MY186726A (en) |
-
2014
- 2014-07-30 MY MYPI2016700339A patent/MY186726A/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12016500182A1 (en) | Anti-activin a antibodies and uses thereof | |
HK1253065A1 (en) | Compounds targeting proteins, compositions, methods, and uses thereof | |
MX2018001532A (en) | Anti-angptl8 antibodies and uses thereof. | |
PH12018500707A1 (en) | Anti-human cd19 antibodies with high affinity | |
PH12016501644B1 (en) | Binding proteins and methods of use thereof | |
PH12014501108A1 (en) | Anti-il-36r antibodies | |
WO2017015622A8 (en) | Gdf11 binding proteins and uses thereof | |
WO2013123432A3 (en) | Histidyl-trna synthetases for treating autoimmune and inflammatory diseases | |
MX2016001236A (en) | Afucosylated anti-fgfr2iiib antibodies. | |
WO2012149356A3 (en) | Anti-cd40 antibodies and methods of use | |
PH12014502406B1 (en) | Anti-il-23p19 antibodies | |
MX2016004551A (en) | Use of semaphorin-4d binding molecules for treatment of atherosclerosis. | |
WO2014078866A3 (en) | Engineered immunoglobulins with extended in vivo half-life | |
MX2013006875A (en) | Anti-notch1 antibodies. | |
MX2015017853A (en) | Lectin-like oxidized ldl receptor1 antibodies and methods of use. | |
MY187513A (en) | Lectin-like oxidized ldl receptor 1 antibodies and methods of use | |
MX2014001766A (en) | Neuregulin antibodies and uses thereof. | |
SG10201805646WA (en) | Angiopoietin-like 4 antibodies and methods of use | |
GB201302343D0 (en) | Pharmaceutical compositions comprising 15-OHEPA and methods for using the same | |
IL237852A0 (en) | Anti amphiregulin antibodies, compositions comprising same and uses thereof | |
MX2016014726A (en) | Her1 antigen binding proteins binding to the beta-hairpin of her1. | |
MY186726A (en) | Anti-activin a antibodies and uses thereof | |
EA202091757A2 (en) | ANTIBODIES TO ACTIVIN A AND THEIR APPLICATION | |
TN2014000207A1 (en) | Anti il-36r antibodies |